Virtual Reality in Orthopedic Rehabilitation

NCT06002139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2023-12-12

No results posted yet for this study

Summary

The study's objective is to evaluate the efficacy of implemented Virtual Reality therapy for patients who have undergone lower limb arthroplasty and are in inpatient rehabilitation. The study aim to examine its influence on reducing anxiety levels, mitigating depressive symptoms, enhancing motivation for elderly patients to participate in physiotherapy, and improving their overall functional state and fall risk.

Conditions

Interventions

BEHAVIORAL

Immersive Virtual Reality Therapy

8 sessions of VR therapy over 4 weeks (each of them 20 minutes long). As a virtual reality source, VRTierOne device (Stolgraf®) were used. Thanks to using head mounted display and the phenomenon of total immersion VR therapy provides an intense visual, auditory and kinesthetic stimulation. It can have a calming and mood-improving effect or help the patients recognize their psychological resources and motivate to the rehabilitation process. In the virtual therapeutic garden there are a rich set of symbols and metaphors based on Ericksonian Psychotherapy approach. The most important is the Garden of Revival which symbolizes the patient's health. It used to be full of life and energy, now it is neglected, requires work to be revived. In the therapeutic process day by day, the therapist tells the patient a symbolic story about his/her situation.

BEHAVIORAL

Conventional rehabilitation

Four weeks of conventional rehabilitation including: * Two hours of kinesiotherapy (120 minutes, including gait training). * Thirty minutes of ergotherapy. * Three physical therapy procedures (i.e. laser therapy, magnetic therapy, electrotherapy) tailored to individual ailments and needs.

Sponsors & Collaborators

  • Wroclaw Medical University

    collaborator OTHER
  • Wroclaw University of Health and Sport Sciences

    collaborator OTHER
  • Jan Dlugosz University in Czestochowa

    collaborator OTHER
  • Joanna Szczepańska-Gieracha

    lead OTHER

Principal Investigators

  • Justyna Mazurek, PhD · Wroclaw Medical University

  • Błażej Cieślik, PhD · Jan Dlugosz University in Czestochowa, Poland

  • Justyna Mazurek, RhD · Wroclaw Medical University

  • Joanna Szczepańska-Gieracha, Professor · Wrocław University of Health and Sport Sciences

  • Robert Gajda, PhD · Gajda-Med District Hospital in Pułtusk

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-09-15
Completion
2023-10-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06002139 on ClinicalTrials.gov